2022 Q1 Form 10-Q Financial Statement

#000165495422001704 Filed on February 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2020 Q4
Revenue $8.687K $4.351M $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $1.448M $1.217M $2.599M
YoY Change 7.86% -53.17% 187.61%
% of Gross Profit
Research & Development $1.249M $885.8K $966.9K
YoY Change -0.79% -8.39% 96.86%
% of Gross Profit
Depreciation & Amortization $76.40K $41.67K $64.63K
YoY Change 18.21% -35.53% 7.15%
% of Gross Profit
Operating Expenses $2.851M $3.118M $0.00
YoY Change 9.61% -100.0%
Operating Profit -$2.843M -$869.7K -$3.566M
YoY Change 9.28% -75.61% 162.13%
Interest Expense $3.298M $4.487M $1.734M
YoY Change 18.96% 158.8% -203.23%
% of Operating Profit
Other Income/Expense, Net $3.298M -$4.487M -$1.734M
YoY Change 18.96% 158.8% -7116.34%
Pretax Income -$6.141M -$5.357M -$5.299M
YoY Change 14.28% 1.08% 75.76%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.141M -$5.357M -$5.299M
YoY Change 14.28% 1.08% 75.76%
Net Earnings / Revenue -70688.82% -123.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$162.1K -$151.0K -$201.3K
COMMON SHARES
Basic Shares Outstanding 36.06M shares 35.97M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.19M $10.73M $2.927M
YoY Change -28.73% 266.69% 94.85%
Cash & Equivalents $11.19M $10.73M $2.927M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $119.2K $3.125M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.31M $13.86M $2.927M
YoY Change -27.97% 373.43% 94.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.037M $672.3K $213.7K
YoY Change 466.73% 214.64% -37.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.77K $13.77K $25.18K
YoY Change 0.0% -45.31% 82.86%
Total Long-Term Assets $1.357M $1.027M $296.6K
YoY Change 542.16% 246.05% -49.48%
TOTAL ASSETS
Total Short-Term Assets $11.31M $13.86M $2.927M
Total Long-Term Assets $1.357M $1.027M $296.6K
Total Assets $12.66M $14.88M $3.224M
YoY Change -20.4% 361.71% 53.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $411.9K $408.5K $580.8K
YoY Change -5.23% -29.66% -27.34%
Accrued Expenses $265.9K $1.508M $1.179M
YoY Change -81.54% 27.98% 2.19%
Deferred Revenue
YoY Change
Short-Term Debt $2.255M $13.38M $5.271M
YoY Change -55.41% 153.78% -0.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.363M $17.42M $7.870M
YoY Change -33.48% 121.38% 8.46%
LONG-TERM LIABILITIES
Long-Term Debt $431.8K $431.8K $0.00
YoY Change 0.0%
Other Long-Term Liabilities $138.6K $171.6K $14.60K
YoY Change 53219.23% 1075.21% -84.13%
Total Long-Term Liabilities $570.4K $603.4K $14.60K
YoY Change 32.03% 4032.77% -84.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.363M $17.42M $7.870M
Total Long-Term Liabilities $570.4K $603.4K $14.60K
Total Liabilities $5.934M $18.03M $7.885M
YoY Change -30.14% 128.62% 7.3%
SHAREHOLDERS EQUITY
Retained Earnings -$92.82M -$86.68M
YoY Change
Common Stock $43.74K $35.97K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.729M -$3.141M -$4.661M
YoY Change
Total Liabilities & Shareholders Equity $12.66M $14.88M $3.224M
YoY Change -20.4% 361.71% 53.91%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income -$6.141M -$5.357M -$5.299M
YoY Change 14.28% 1.08% 75.76%
Depreciation, Depletion And Amortization $76.40K $41.67K $64.63K
YoY Change 18.21% -35.53% 7.15%
Cash From Operating Activities $885.8K -$1.908M -$1.421M
YoY Change -148.5% 34.26% 72.38%
INVESTING ACTIVITIES
Capital Expenditures -$441.5K -$385.5K -$9.630K
YoY Change 1642.19% 3903.01% -37.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$441.5K -$385.5K -$9.633K
YoY Change 1642.19% 3901.74% -37.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.344K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.000K $768.8K $59.69K
YoY Change -99.94% 1188.08% -86.47%
NET CHANGE
Cash From Operating Activities 885.8K -$1.908M -$1.421M
Cash From Investing Activities -441.5K -$385.5K -$9.633K
Cash From Financing Activities 9.000K $768.8K $59.69K
Net Change In Cash 453.3K -$1.524M -$1.371M
YoY Change -96.45% 11.2% 244.0%
FREE CASH FLOW
Cash From Operating Activities $885.8K -$1.908M -$1.421M
Capital Expenditures -$441.5K -$385.5K -$9.630K
Free Cash Flow $1.327M -$1.522M -$1.411M
YoY Change -173.7% 7.86% 74.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
12258218 USD
CY2021Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
3124581 USD
CY2021Q3 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
0 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36060912 shares
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13858324 USD
CY2021Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
10733743 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1508301 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
12258218 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
672320 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
328504 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
13767 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
13767 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340448 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
289002 USD
CY2021Q4 us-gaap Assets
Assets
14884859 USD
CY2021Q3 us-gaap Assets
Assets
12889491 USD
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
408508 USD
CY2021Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
419093 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
893137 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1961685 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
421599 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
13375812 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
9191155 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
168624 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
112371 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17422930 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11037355 USD
CY2021Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
431803 USD
CY2021Q3 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
431803 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
171582 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
178170 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
603385 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
609973 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35969912 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35166551 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
35971 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
35168 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83502881 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82530684 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86683113 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81326494 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3141456 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1242163 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14884859 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12889491 USD
CY2021Q4 knwn Revenue
REVENUE
4351400 USD
CY2020Q4 knwn Revenue
REVENUE
0 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
885752 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
966861 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
3118360 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
0 USD
CY2021Q4 knwn Research And Development Expense And Operating Expense
ResearchAndDevelopmentExpenseAndOperatingExpense
5221059 USD
CY2020Q4 knwn Research And Development Expense And Operating Expense
ResearchAndDevelopmentExpenseAndOperatingExpense
3565593 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-869659 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3565593 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
4486960 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
1733738 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4486960 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1733738 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5356619 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5299331 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-5356619 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-5299331 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35479073 shares
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25208726 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1914911 USD
CY2020Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
175442 USD
CY2020Q4 knwn Issuance Of Warrants For Services Related To Debt Offering Note7 Amount
IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7Amount
561600 USD
CY2020Q4 knwn Issuance Of Warrant For Services To Related Party
IssuanceOfWarrantForServicesToRelatedParty
1811691 USD
CY2020Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
4688 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-5299331 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4660822 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1242163 USD
CY2021Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
204170 USD
CY2021Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
766486 USD
CY2021Q4 knwn Issuance Of Common Stock For Stock Option Exercises Amount
IssuanceOfCommonStockForStockOptionExercisesAmount
2344 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-5356619 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3141456 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-5356619 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-5299331 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41672 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64633 USD
CY2021Q4 knwn Stock Based Compensation Warrants
StockBasedCompensationWarrants
0 USD
CY2020Q4 knwn Stock Based Compensation Warrants
StockBasedCompensationWarrants
1811691 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
204170 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
175442 USD
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4184657 USD
CY2020Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1596980 USD
CY2021Q4 knwn Right Of Use Net
RightOfUseNet
-1781 USD
CY2020Q4 knwn Right Of Use Net
RightOfUseNet
-565 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-3124581 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2144665 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
230150 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1907817 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1421000 USD
CY2021Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
385488 USD
CY2020Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9633 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-385488 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9633 USD
CY2021Q4 knwn Proceeds From Simple Agreements For Future Equity
ProceedsFromSimpleAgreementsForFutureEquity
0 USD
CY2020Q4 knwn Proceeds From Simple Agreements For Future Equity
ProceedsFromSimpleAgreementsForFutureEquity
55000 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2344 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
766486 USD
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4688 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
768830 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59688 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1524475 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1370945 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12258218 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4298179 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10733743 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2927234 USD
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q4 knwn Conversion Of Debt Offering
ConversionOfDebtOffering
0 USD
CY2020Q4 knwn Conversion Of Debt Offering
ConversionOfDebtOffering
520000 USD
CY2021Q4 knwn Conversion Of Accrued Interest
ConversionOfAccruedInterest
0 USD
CY2020Q4 knwn Conversion Of Accrued Interest
ConversionOfAccruedInterest
41599 USD
CY2021Q4 knwn Authorized Shares Of Capital Common Stock
AuthorizedSharesOfCapitalCommonStock
205000000 shares
CY2021Q3 knwn Authorized Shares Of Capital Common Stock
AuthorizedSharesOfCapitalCommonStock
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 knwn Authorized Common Stock Increased
AuthorizedCommonStockIncreased
200000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10733743 USD
CY2021Q4 knwn Working Capital
WorkingCapital
9979830 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86683113 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14209000 USD
CY2021Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2021Q1 knwn Warrants In Private Placement To Accredited Investors
WarrantsInPrivatePlacementToAccreditedInvestors
3552250 shares
CY2021Q1 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
2.00
CY2021Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 USD
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
10483743 USD
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12008228 USD
CY2021Q4 knwn Revenue Recognition Policy Textblock
RevenueRecognitionPolicyTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Revenue Recognition </strong>- The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.25in; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.. During the three months ended December 31, 2021, the Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s. The Company engineering team, using its research date, AI and proprietary algorithms, produced NFT’s in the form of digital art. The NFT’s produced had no recorded cost basis. </p>
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
885752 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3969972 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2033726 USD
CY2021Q4 us-gaap Advertising Expense
AdvertisingExpense
294391 USD
CY2020Q4 us-gaap Advertising Expense
AdvertisingExpense
118750 USD
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
10483743 USD
CY2021Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
12217714 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35969912 shares
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
16124764 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
16464066 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25370224 shares
CY2020Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
14189764 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
7424566 shares
CY2021Q4 knwn Property Plant And Equipment Disclosure Text Block2170aa
PropertyPlantAndEquipmentDisclosureTextBlock2170aa
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. Artificial Intelligence (AI) Deep Learning Platform</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>AI Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended December 31, 2021,<strong> </strong>the<strong> </strong>Company’s artificial intelligence (AI) Deep Learning Platform began generating revenue from digital asset sales of NFT’s and had sales of $4,351,400. The Company’s sales of NFT’s are generated using the NFT digital exchange, OpenSea. Customers purchasing the NFT’s must make payments in the crypto currency, Ethereum. The Ethereum is received into a digital wallet and then moved to an account at Coinbase where the Ethereum is converted to U.S. dollars. During the quarter ended December 31, 2021, the Company was not able to establish a digital wallet and corporate account at Coinbase in order to receive the Ethereum. The Company used the digital wallet and Coinbase account of the Company’s CEO. The Company and the CEO executed an assignment of his account to the Company while the Company establishes its own Coinbase account. All proceeds received from the sale of NFT were deposited in the CEO’s personal digital accounts. As of December 31, 2021 the Company has recorded an accounts receivable-related party of $3,124,581 for the cash it expects to receive from the CEO’s personal digital account. Included in accrued expenses-related party at December 31, 2021 is approximately $1.56 million of special bonus compensation the Company expects to pay employees and its CEO for the NFT sales once the cash is received. As of December 31, 2021, accrued expenses include approximately $326,000 of expenses, primarily sales and use tax, that the Company expects to pay for the NFT sales. During 2021, approximately $1.3 million of the selling and transactional costs for the digital assets was paid through the CEO”s personal digital asset account including approximately $1.075 million which was paid to a consultant via the transfer of Ethereum. </p>
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1040285 USD
CY2021Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
654798 USD
CY2021Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3612 USD
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3612 USD
CY2021Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
26855 USD
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
26855 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
398432 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
356761 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
672320 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
328504 USD
CY2021Q4 us-gaap Depreciation
Depreciation
41672 USD
CY2020Q4 us-gaap Depreciation
Depreciation
21300 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340448 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
340206 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
290000 USD
CY2021Q4 us-gaap Lease Cost
LeaseCost
40629 USD
CY2020Q4 us-gaap Lease Cost
LeaseCost
37612 USD
CY2021Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
50051 USD
CY2021Q4 knwn Finance Leases Weighted Average Remaining Lease Term
FinanceLeasesWeightedAverageRemainingLeaseTerm
P28Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
150811 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
134537 USD
CY2021Q4 knwn Convertible Notes Conversions
ConvertibleNotesConversions
0 USD
CY2021Q3 knwn Convertible Notes Conversions
ConvertibleNotesConversions
-5639500 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
82232 USD
CY2021Q4 knwn Total Remaining Payments
TotalRemainingPayments
367581 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
340206 USD
CY2021Q4 knwn Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
-1845841 USD
CY2021Q3 knwn Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
-4308337 USD
CY2021Q4 knwn Debt Discount Warrants
DebtDiscountWarrants
-838640 USD
CY2021Q3 knwn Debt Discount Warrants
DebtDiscountWarrants
-1957590 USD
CY2021Q4 knwn Debt Discount Warrants Issued For Services
DebtDiscountWarrantsIssuedForServices
-453773 USD
CY2021Q3 knwn Debt Discount Warrants Issued For Services
DebtDiscountWarrantsIssuedForServices
-1056984 USD
CY2021Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
9191155 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35969912 shares
CY2021Q4 knwn Options To Purchase Common Stock Share
OptionsToPurchaseCommonStockShare
18423245 shares
CY2021Q4 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned
11775745 shares
CY2021Q4 knwn Warrant Issued To Common Stock
WarrantIssuedToCommonStock
21654013 shares
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
16464066 USD
CY2021Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
16124764 shares
CY2021Q4 us-gaap Shares Issued
SharesIssued
801486 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22564255 shares
CY2021Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
801486 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
108756 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21654013 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.999
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
21654013 shares
CY2021Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
21654013 USD
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
15800709 USD
CY2021Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
204170 USD
CY2020Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
119483 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5717669 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y11M23D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9180369 USD
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.142
CY2020 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted
3522400 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18298 USD
CY2020 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures
-7103921 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.161
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5580550 USD
CY2021 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted
18807990 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
28031 USD
CY2021 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures
-396000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23964509 USD
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.090
CY2021Q4 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted
6499900 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2344 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30462065 USD
CY2021Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
3124581 USD
CY2021Q4 knwn Special Bonus Compensation
SpecialBonusCompensation
1560000 USD
CY2021Q4 knwn Sales And Use Tax
SalesAndUseTax
326000 USD
CY2021Q4 knwn Selling And Transactional Costs
SellingAndTransactionalCosts
1300000 USD
CY2021Q4 knwn Amount Paid To Consultant
AmountPaidToConsultant
1075000.000 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
3334 USD
CY2017Q2 knwn Lease Description
LeaseDescription
lease expires on May 31, 2022
CY2021Q4 knwn Lease Description
LeaseDescription
the Company extended the lease from June 1, 2022 to May 31, 2023 at $2,986 per month.
CY2019Q1 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
8697 USD
CY2019Q1 knwn Lease Description
LeaseDescription
The lease expires on June 30, 2024
CY2021Q4 knwn Lease Description
LeaseDescription
the Company entered into First Amendment of Lease and added 1,030 square feet for year for $1,000 for $5,000 per month.
CY2021Q4 knwn Segment Revenues
SegmentRevenues
4351000 USD
CY2021Q4 knwn Segment Net Income Loss
SegmentNetIncomeLoss
-869000 USD
CY2021Q4 knwn Segment Assets
SegmentAssets
14885000 USD
CY2020Q4 knwn Segment Net Income Loss
SegmentNetIncomeLoss
-3565000 USD
CY2020Q4 knwn Segment Assets
SegmentAssets
3224000 USD
CY2021Q4 us-gaap Other Noncash Expense
OtherNoncashExpense
4428718 USD
CY2020Q4 us-gaap Other Noncash Expense
OtherNoncashExpense
3648181 USD

Files In Submission

Name View Source Status
0001654954-22-001704-index-headers.html Edgar Link pending
0001654954-22-001704-index.html Edgar Link pending
0001654954-22-001704.txt Edgar Link pending
0001654954-22-001704-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
knwn-20211231.xsd Edgar Link pending
knwn-20211231_cal.xml Edgar Link unprocessable
knwn-20211231_def.xml Edgar Link unprocessable
knwn-20211231_lab.xml Edgar Link unprocessable
knwn-20211231_pre.xml Edgar Link unprocessable
knwn_10q.htm Edgar Link pending
knwn_10qimg1.jpg Edgar Link pending
knwn_10q_htm.xml Edgar Link completed
knwn_ex1020.htm Edgar Link pending
knwn_ex1021.htm Edgar Link pending
knwn_ex311.htm Edgar Link pending
knwn_ex312.htm Edgar Link pending
knwn_ex321.htm Edgar Link pending
knwn_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending